J&J | JNJ - Assets



J&J reported $193.67B in Assets for its fiscal quarter ending in March of 2025.


Assets Change Date
AbbVie USD 136.17B 1B Mar/2025
Abbott USD 84B 2.55B Jun/2025
Amgen USD 87.9B 1.47B Jun/2025
AstraZeneca USD 112.42B 6.17B Jun/2025
Baxter International USD 21.3B 4.48B Mar/2025
Bayer EUR 105.24B 3.95B Jun/2025
Becton, Dickinson and Co. USD 54.9B 435M Jun/2025
Biogen USD 28.33B 297.1M Jun/2025
Boston Scientific USD 40.14B 745M Mar/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
CONMED USD 2.33B 30.78M Jun/2025
Cooper Companies USD 12.38B 36.9M Jul/2025
Dexcom USD 7.33B 575.3M Jun/2025
Edwards Lifesciences USD 13.02B 33M Mar/2025
Eli Lilly USD 100.92B 11.53B Jun/2025
Gilead Sciences USD 55.72B 713M Jun/2025
GlaxoSmithKline GBP 59.26B 1.45B Jun/2025
Globus Medical USD 4.96B 249.94M Jun/2025
Hologic USD 8.81B 261M Jun/2025
Insulet USD 3.47B 48.1M Jun/2025
Integra LifeSciences USD 3.67B 384.85M Jun/2025
Intuitive Surgical USD 20.16B 942.8M Jun/2025
J&J USD 193.67B 13.57B Mar/2025
Medtronic USD 91.68B 1.71B Apr/2025
Merck USD 117.52B 2.4B Jun/2025
Merit Medical Systems USD 2.59B 118.07M Jun/2025
Novartis USD 104.4B 4.45B Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
Regeneron Pharmaceuticals USD 38.22B 674M Jun/2025
Roche Holding CHF 101.8B 6.02B Dec/2024
Sanofi 124.96B 6.93B Jun/2025
Stryker USD 46.33B 325M Jun/2025
Tandem Diabetes Care USD 875.74M 46.41M Jun/2025
Teva Pharmaceutical Industries USD 40.13B 1.72B Jun/2025
Vertex Pharmaceuticals USD 24.04B 1.16B Jun/2025
Zimmer Biomet Holdings USD 22.87B 681.2M Jun/2025
Zoetis USD 14.48B 381M Jun/2025